TrialSignal
Clinical trial intelligence report
Molke Oder Casein - Leberfettreduktion Und Stoffwechselverbesserung Durch Schnelle vs. Langsame Proteine (Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins)
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04564391-Jul 28, 2026
NCT ID
NCT04564391
Status
UNKNOWN
Phase
NA
Sponsor
Charite University, Berlin, Germany
Executive brief
Investment-Ready Snapshot
Molke Oder Casein
Leberfettreduktion Und Stoffwechselverbesserung Durch Schnelle vs. Langsame Proteine (Whey or Casein
Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins) is a NA clinical asset sponsored by Charite University, Berlin, Germany in Type2 Diabetes, NAFLD. SEO and diligence focus: protein supplement, placebo supplement, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04564391
Indication
Type2 Diabetes
Modality
protein therapy
Target
protein supplement, placebo supplement
Intervention
protein supplement, placebo supplement
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.